Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
The Committee considers that the actual benefit of ALTIM remains substantial in rheumatological diseases : - In intra-articular injection: inflammatory arthritis, advanced osteoarthritis. - In periarticular injection: tendinitis, bursitis. - In injection of soft tissue: talalgia, carpal tunnel syndrome, Dupuytren's contracture. |
| Unspecified |
The Committee does not make any comment on the actual benefit of ALTIM in the epidural injection indication : radiculalgia, pending the re-assessment of ALTIM 3.75 mg/1.5 ml suspension for injection an d HYDROCORTANCYL 2.5 % suspension for injection in this single indication. |
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
SJz87Tkux72Hf8E2
